y0news
AnalyticsDigestsSourcesTopicsRSSAICrypto

#drug-design News & Analysis

5 articles tagged with #drug-design. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.

5 articles
AIBullisharXiv – CS AI · May 277/10
🧠

Co-folding model guided by structural proteomics

Researchers introduce AIMS-Fold, a guided-diffusion framework that integrates structural proteomics data (XL-MS and HDX-MS measurements) with protein structure prediction models to improve accuracy in predicting protein complex conformations. The approach outperforms unguided computational models on challenging induced proximity drug targets, advancing structure-based drug design capabilities.

AINeutralarXiv – CS AI · Jun 86/10
🧠

ShallowBench: Benchmarking Generative Drug Design Models on Shallow-Pocket Targets

Researchers introduce ShallowBench, a curated benchmark of 5,780 shallow-pocket protein targets, revealing that current generative AI drug design models struggle with low-concavity binding sites common in challenging oncology targets like KRAS and MYC. The benchmark highlights a critical gap in generative biology that requires new architectural innovations to address historically undruggable targets.

AIBullisharXiv – CS AI · Jun 26/10
🧠

Probe Before You Edit: Probing-Guided Molecular Optimization for LLM Agents in Structure-Based Drug Design

Researchers introduce PROBE, a novel optimization framework that enables LLM agents to design drugs more effectively by probing molecular structures before making edits. The method addresses a critical failure in current drug-design pipelines: agents often sacrifice druggability when optimizing for binding affinity. PROBE achieves state-of-the-art results on standard benchmarks by mimicking how medicinal chemists strategically explore chemical modifications.

AINeutralarXiv – CS AI · Jun 26/10
🧠

On the Collapse of Generative Paths: A Criterion and Correction for Diffusion Steering

Researchers identify Marginal Path Collapse, a failure mode in diffusion model steering where intermediate densities become non-normalizable despite valid endpoints. They propose Adaptive Path Correction with Exponents (ACE), a framework using time-varying exponents to stabilize compositional sampling in drug design and image generation tasks.

AINeutralarXiv – CS AI · May 126/10
🧠

From Holo Pockets to Electron Density: GPT-style Drug Design with Density

Researchers introduce EDMolGPT, a generative AI model that uses electron density data from protein binding pockets to design novel drug molecules. The approach improves upon existing methods by incorporating physically grounded density information rather than empty pocket structures, enabling more accurate molecular generation with realistic 3D conformations.